Official recall notice

FDA DrugClass IIINotable

FDA Recall: Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATOR

Recall date
2026-06-03
Category
Drug
FDA class
Class III

Why it was recalled

Hazard

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Recommended action

What to do

59,808 pouches (4,272 Individual Folding Carton (IFC))

Product description

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.

Verify with the official notice →
Share:

Related Recalls

2026-09-03 · FDA_DRUG
FDA Recall: B. Braun: 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container
B. Braun
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for:
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Ac
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinc
Mallinckrodt Hospital Products Inc.